Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 14Active not recruiting 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 562Specimen Handling 489Carboplatin 451Magnetic Resonance Spectroscopy 443Cyclophosphamide 418Cisplatin 408Radiotherapy 354Gemcitabine 316Bevacizumab 313Paclitaxel 300Biopsy 290Drug Therapy 285Blood Specimen Collection 248Capecitabine 245Oxaliplatin 242fludarabine 239Nivolumab 236venetoclax 221Injections 213Docetaxel 209Fluorouracil 205Dexamethasone 187Radiosurgery 184Rituximab 161Standard of Care 158Pemetrexed 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 144Leucovorin 138

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × LY-2157299 × Clear all
NCT05700656 2024-07-22

Galunisertib Combined With Capecitabine in Advanced CRC With PM

The Netherlands Cancer Institute

Phase 1/2 Recruiting
31 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡